Related references
Note: Only part of the references are listed.Preparation and In Vitro Evaluation of RITUXfab-Decorated Lipoplexes to Improve Delivery of siRNA Targeting C1858T PTPN22 Variant in B Lymphocytes
Andrea Arena et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Functions and therapeutic targets of Siglec-mediated infections, inflammations and cancers
Chia-Hsueh Lin et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2021)
Sialic Acid-Siglec Axis in Human Immune Regulation, Involvement in Autoimmunity and Cancer and Potential Therapeutic Treatments
Elena Gianchecchi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Type 1 diabetes linked PTPN22 gene polymorphism is associated with the frequency of circulating regulatory T cells
Milla Valta et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2020)
Siglec-10 expression is up-regulated in activated human CD4+ T cells
E. Bandala-Sanchez et al.
HUMAN IMMUNOLOGY (2020)
Anti-CD20–mediated B-cell depletion in autoimmune diseases: successes, failures and future perspectives
Etienne Crickx et al.
KIDNEY INTERNATIONAL (2020)
Type 1 diabetes-early life origins and changing epidemiology
Jill M. Norris et al.
LANCET DIABETES & ENDOCRINOLOGY (2020)
The role of metabolic checkpoint regulators in B cell survival and transformation
Julia Jellusova
IMMUNOLOGICAL REVIEWS (2020)
Immunotherapy Strategies for the Prevention and Treatment of Distinct Stages of Type 1 Diabetes: An Overview
Novella Rapini et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes
Kevan C. Herold et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Anti-CD3 Antibody for the Prevention of Type 1 Diabetes: A Story of Perseverance
Jason Gaglia et al.
BIOCHEMISTRY (2019)
Specific Sialoforms Required for the Immune Suppressive Activity of Human Soluble CD52
Abdulrahman M. Shathili et al.
FRONTIERS IN IMMUNOLOGY (2019)
Autoimmune polyglandular diseases
George J. Kahaly et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Chronic Immune Activation in Systemic Lupus Erythematosus and the Autoimmune PTPN22 Trp620 Risk Allele Drive the Expansion of FOXP3+ Regulatory T Cells and PD-1 Expression
Ricardo C. Ferreira et al.
FRONTIERS IN IMMUNOLOGY (2019)
Exploiting novel tailored immunotherapies of type 1 diabetes: Short interfering RNA delivered by cationic liposomes enables efficient down-regulation of variant PTPN22 gene in T lymphocytes
Marsha Pellegrino et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2019)
CD52 glycan binds the proinflammatory B box of HMGB1 to engage the Siglec-10 receptor and suppress human T cell function
Esther Bandala-Sanchez et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Association of obesity and diabetes with thyroid nodules
Silvio Buscemi et al.
ENDOCRINE (2018)
CTLA-4+49 G/A Polymorphism Confers Autoimmune Disease Risk: An Updated Meta-Analysis
Ke Wang et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS (2017)
The immunological function of CD52 and its targeting in organ transplantation
Yang Zhao et al.
INFLAMMATION RESEARCH (2017)
The common, autoimmunity-predisposing 620Arg > Trp variant of PTPN22 modulates macrophage function and morphology
Meihang Li et al.
JOURNAL OF AUTOIMMUNITY (2017)
Use of short interfering RNA delivered by cationic liposomes to enable efficient down-regulation of PTPN22 gene in human T lymphocytes
Valentina Perri et al.
PLOS ONE (2017)
CRISPR-Cas9-Mediated Modification of the NOD Mouse Genome With Ptpn22R619W Mutation Increases Autoimmune Diabetes
Xiaotian Lin et al.
DIABETES (2016)
Sialic Acid Mimetics to Target the Sialic Acid-Siglec Axis
Christian Bull et al.
TRENDS IN BIOCHEMICAL SCIENCES (2016)
Structural characterisation of high affinity Siglec-2 (CD22) ligands in complex with whole Burkitt's lymphoma (BL) Daudi cells by NMR spectroscopy
Paul D. Madge et al.
SCIENTIFIC REPORTS (2016)
Effect of Associated Autoimmune Diseases on Type 1 Diabetes Mellitus Incidence and Metabolic Control in Children and Adolescents
Aleksandra Krzewska et al.
BIOMED RESEARCH INTERNATIONAL (2016)
Insulin gene VNTR polymorphisms-2221MspI and-23HphI are associated with type 1 diabetes and latent autoimmune diabetes in adults: a meta-analysis
Na Zhang et al.
ACTA DIABETOLOGICA (2015)
Impact of disease heterogeneity on treatment efficacy of immunotherapy in Type 1 diabetes: different shades of gray
Nicky J. C. Woittiez et al.
IMMUNOTHERAPY (2015)
Siglec-10 is associated with survival and natural killer cell dysfunction in hepatocellular carcinoma
Pei Zhang et al.
JOURNAL OF SURGICAL RESEARCH (2015)
The role of CD22 and Siglec-G in B-cell tolerance and autoimmune disease
Jennifer Mueller et al.
NATURE REVIEWS RHEUMATOLOGY (2014)
Altered B Cell Homeostasis and Toll-Like Receptor 9-Driven Response in Type 1 Diabetes Carriers of the C1858T PTPN22 Allelic Variant: Implications in the Disease Pathogenesis
Elena Gianchecchi et al.
PLOS ONE (2014)
The putative role of the C1858T polymorphism of protein tyrosine phosphatase PTPN22 gene in autoimmunity
Elena Gianchecchi et al.
AUTOIMMUNITY REVIEWS (2013)
T cell regulation mediated by interaction of soluble CD52 with the inhibitory receptor Siglec-10
Esther Bandala-Sanchez et al.
NATURE IMMUNOLOGY (2013)
Improving diabetes care in resource-poor countries: challenges and opportunities
Mark A. Atkinson et al.
LANCET DIABETES & ENDOCRINOLOGY (2013)
Click and Pick: Identification of Sialoside Analogues for Siglec-Based Cell Targeting
Cory D. Rillahan et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2012)
PTPN22 Alters the Development of Regulatory T Cells in the Thymus
Christian J. Maine et al.
JOURNAL OF IMMUNOLOGY (2012)
The association between the PTPN22 C1858T polymorphism and systemic lupus erythematosus: a meta-analysis update
W. W. Lea et al.
LUPUS (2011)
Functionally defective germline variants of sialic acid acetylesterase in autoimmunity
Ira Surolia et al.
NATURE (2010)
Genetics of the Autoimmune Polyglandular Syndrome Type 3 Variant
Manuela Dittmar et al.
THYROID (2010)
The protein tyrosine phosphatase nonreceptor 22 (PTPN22) is associated with high GAD antibody titer in latent autoimmune diabetes in adults -: Non Insulin Requiring Autoimmune Diabetes (NIRAD) study 3
Antonio Petrone et al.
DIABETES CARE (2008)
Siglecs and their roles in the immune system
Paul R. Crocker et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Role of the spacer stereochemistry on the aggregation properties of cationic gemini surfactants
Cristiano Bello et al.
LANGMUIR (2006)
LFA-1 (CD11a) as a therapeutic target
MR Nicolls et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant
T Vang et al.
NATURE GENETICS (2005)
A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes
N Bottini et al.
NATURE GENETICS (2004)